Clinical Trial Search Results - Adventist HealthCare

Clinical Trial Search Results

Showing 1-6 of 6

Sorted By:

  • ARCTIC

    Randomised, open label, multi-centre study assessing the efficacy and safety of MEDI4736 versus Standard of Care in NSCLC patients with PD-L1 positive tumours.

  • Ceritinib with Low-fat Meal

    Study to assess the systemic exposure, effiacy, and safety of 450 mg ceritinib taken with a low-fat meal and 600 mg ceritinib taken with a low-fat meal.

  • IMpower 131

    Randomized, open-label study to evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin + paclitaxel or carboplatin + nab-paclitaxel.

  • IMpower 150

    Randomized, open-label study will evaluate the safety and efficacy of Atezolizumab (MPDL3280A) in combination with carboplatin and paclitaxel.

  • NSCLC

    A Phase I study to assess the systemic exposure, effiacy, and safety of 450 mg ceritinib taken with a low-fat meal and 600 mg ceritinib taken with a low-fat meal.

  • PACIFIC

    Global study to assess the effects of MEDI4736 following concurrent chemoradiation in patients with Stage III unresectable non-small cell lung cancer.

Page InfoPage
Showing trials 1-6 of 6

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.